tiprankstipranks
Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Shareholders
PremiumPress ReleasesVeru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Shareholders
18d ago
Veru to Present at the American Diabetes Association’s 84th Scientific Sessions
PremiumPress Releases
Veru to Present at the American Diabetes Association’s 84th Scientific Sessions
25d ago
Veru to Present at the Jefferies Global Healthcare Conference
PremiumPress Releases
Veru to Present at the Jefferies Global Healthcare Conference
1M ago
Veru Inc Reports Earnings: Did it Beat Estimate Forecasts?
PremiumEarning ReleasesVeru Inc Reports Earnings: Did it Beat Estimate Forecasts?
2M ago
Veru reports Q2 EPS (7c), consensus (5c)
PremiumThe Fly
Veru reports Q2 EPS (7c), consensus (5c)
2M ago
Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program
PremiumPress Releases
Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program
2M ago
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
PremiumPress ReleasesVeru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
2M ago
Veru enrolls first patients in Phase 2b trial of enobosarm, semaglutide
PremiumThe Fly
Veru enrolls first patients in Phase 2b trial of enobosarm, semaglutide
2M ago
Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
PremiumPress Releases
Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100